Skip to content

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    AAN 2023
    BNA 2023
    AD/PD 2023
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Carlo Colosimo

Updates on the development of treatments for MSA 2:07
Updates on the development of treatments for MSA
Carlo Colosimo • 16 Sep 2022
MSA: challenges with early diagnosis 2:31
MSA: challenges with early diagnosis
Carlo Colosimo • 16 Sep 2022
Movement disorders in oncology: immune checkpoint inhibitors 2:22
Movement disorders in oncology: immune checkpoint inhibitors
Carlo Colosimo • 16 Sep 2022
Management of iatrogenic hyperkinetic movement disorders 2:58
Management of iatrogenic hyperkinetic movement disorders
Carlo Colosimo • 16 Sep 2022
Recognizing iatrogenic movement disorders 1:58
Recognizing iatrogenic movement disorders
Carlo Colosimo • 16 Sep 2022
DBS & FUS: improvements for the treatment of Parkinson’s disease 1:13
DBS & FUS: improvements for the treatment of Parkinson’s disease
Carlo Colosimo • 27 Jun 2022
Updates on levodopa infusion therapies for advanced Parkinson’s disease 1:27
Updates on levodopa infusion therapies for advanced Parkinson’s disease
Carlo Colosimo • 27 Jun 2022
Genetic testing for dystonia 1:20
Genetic testing for dystonia
Carlo Colosimo • 27 Jun 2022
Advances in Parkinson’s disease biomarkers 1:49
Advances in Parkinson’s disease biomarkers
Carlo Colosimo • 27 Jun 2022
Highlights in Parkinson’s disease: subtyping & prodrome 1:40
Highlights in Parkinson’s disease: subtyping & prodrome
Carlo Colosimo • 27 Jun 2022
Long-term effect of botulinum toxin in cervical dystonia 3:24
Long-term effect of botulinum toxin in cervical dystonia
Carlo Colosimo • 7 Sep 2020
Atypical Parkinsonisms: clinical overview & challenges 3:28
Atypical Parkinsonisms: clinical overview & challenges
Carlo Colosimo • 7 Sep 2020
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy